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EMG1Ribosomes are the cellular machines responsible for protein synthesis. Ribosome biogenesis, the production of
ribosomes, is a complex process involving pre-ribosomal RNA (rRNA) cleavages and modiﬁcations as well as
ribosomal protein assembly around the rRNAs to create the functional ribosome. The small subunit (SSU)
processome is a large ribonucleoprotein (RNP) in eukaryotes required for the assembly of the SSU of the ribo-
some as well as for the maturation of the 18S rRNA. Despite the fundamental nature of the SSU processome to
the survival of any eukaryotic cell, mutations in SSU processome components have been implicated in human dis-
eases. Three SSUprocessome components and their related human diseaseswill be explored in this review: hUTP4/
Cirhin, implicated in North American Indian childhood cirrhosis (NAIC); UTP14, implicated in infertility, ovarian
cancer, and scleroderma; and EMG1, implicated in Bowen–Conradi syndrome (BCS). Diseases with suggestive,
though inconclusive, evidence for the involvement of the SSU processome in their pathogenesis are also discussed,
including a novel putative ribosomopathy. This article is part of a Special Issue entitled: Role of the Nucleolus in
Human Disease.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Ribosome biogenesis is a fundamental process that is necessary for
dividing or metabolically active cells. Interestingly, all three RNA poly-
merases (RNAPs) and over 200 assembly factors are required to manu-
facture the ribosome in the eukaryotic nucleolus. In humans, RNAPI
transcribes the 47S precursor pre-rRNA that is processed into the 18S,
5.8S, and 28S rRNAs. RNAPII transcribes the mRNAs for the ribosomal
proteins and ribosome biogenesis proteins [1]. RNAPII also transcribes
the U3, U8, and U13 small nucleolar (sno) RNAs, which are non-
coding RNAs required for 18S rRNA maturation [2]. Finally, RNAPIII
transcribes the 5S rRNA. This transcriptional complexity is matched by
the numerous pre-rRNA processing events required to make the fully
mature rRNAs, the functional catalytic (large subunit; LSU) and recogni-
tion (small subunit; SSU) components of the ribosome [1].
Tomake the small subunit of the ribosome, eukaryotic cells use a large
ribonucleoprotein (RNP) called the SSU processome [3]. The SSU
processome is assembled co-transcriptionally with the 47S pre-rRNA in
the nucleolus [4] and contains the U3 snoRNA as well as over 70e Nucleolus in Human Disease.
ophysics and Biochemistry, P.O.
03 785 4618.
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ights reserved.associated proteins including the U3 proteins (UTPs). The assembly of
the small ribosomal subunit and the maturation of the 18S rRNA, which
is incorporated in the small subunit, require the SSU processome [5].
The SSU processomewas ﬁrst identiﬁed and puriﬁed from the yeast, Sac-
charomyces cerevisiae [3], and later identiﬁed in humans [6].
Since ribosome biogenesis is a vital cellular process, it is surpris-
ing that some defects in ribosome assembly cause human disease
in speciﬁc cell-types without affecting all tissues. These diseases,
termed ribosomopathies, are caused by mutations in various factors
involved in ribosome biogenesis including RNAPI transcription in
Treacher Collins syndrome [7]; large subunit biogenesis in alopecia,
neurological defects, and endocrinopathy (ANE) syndrome and
Shwachman–Diamond syndrome; snoRNPs in Dyskeratosis congenita
and Prader–Willi syndrome [8]; and ribosomal proteins in Diamond–
Blackfan Anemia (DBA) [9] and isolated congenital asplenia (ICA) [10].
Mutations in components of the SSU processome also cause human
diseases.
Three ribosomopathies caused by mutations in components of the
SSU processome resulting in nucleolar dysfunction will be described
here. These SSU processome components and their respective diseases
are: hUTP4/Cirhin—North American Indian childhood cirrhosis (NAIC);
UTP14—infertility, ovarian cancer, and scleroderma; and EMG1—
Bowen–Conradi syndrome (BCS). As with all ribosomopathies, the tissue
proclivity of these diseases is a conundrum, and therein lies the need to
elucidate the molecular mechanisms of their pathogenesis. In addition,
studies suggesting that SSU processome components modify
Fig. 1. Interactome map of the yeast Utp4-containing protein t-Utp/UtpA subcomplex.
Blue shading indicates proteins not conserved to metazoans [16]. Reprinted with
permission.
Fig. 2. The R565WNAICmutation in the context of the C-terminal portion of hUTP4/Cirhin
causes reduced interaction with NOL11 by Y2H analysis [19]. Reprinted with permission.
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examined. Finally, evidence suggestive that Williams–Beuren syn-
drome is a novel ribosomopathy is proposed.
2. Disease of hUTP4/Cirhin: North American Indian childhood
cirrhosis (NAIC)
North American Indian childhood cirrhosis (NAIC) (OMIM: 604901),
ﬁrst discovered in 1970, is a rare, autosomal recessive familial cholesta-
sis found exclusively in Ojibway-Cree children from a First Nations Ca-
nadian population. The incidence of the disease is estimated to be
from1 in 250 to 1 in 750Ojibway-Cree children. Themost recent clinical
report on the disease states that 12 of the total 36 patients diagnosed
with NAIC have had liver transplantation, with no recurrence of disease
after transplantation.With a survival to adulthood of less than 50%, only
17 patients in total were still alive [11]. The disease ﬁrst presents with
neonatal jaundice, progressing to biliary cirrhosis and portal hyperten-
sion. Unfortunately, the only known treatment is liver transplantation
[12]. In most cases, NAIC is histologically identical to the pathology
seen in extrahepatic biliary tree obstruction [11].
Using DNA pooling, the candidate gene for the disease, which was
named CIRH1A, was localized to chromosome 16q22 [13]. Subsequent-
ly, SNP analysis of this region revealed an R565W mutation in human
UTP4/Cirhin (hUTP4/Cirhin) to be present in the patient population
[14]. It has an unusually high estimated carrier frequency of 8–12% in
the Ojibway-Cree population [12]. Utp4 was ﬁrst described in yeast as
part of the original puriﬁcation of the SSU processome [3]. Additionally,
yeast Utp4was shown to be amember of the t-Utp/UtpA subcomplex of
the SSU processome, required for pre-rRNA processing and transcrip-
tion, as well as for the assembly of the SSU processome [4]. hUTP4/
Cirhin, also a member of the human t-UTP/UTPA subcomplex, is re-
quired for pre-18S rRNA processing, but surprisingly is not required
for pre-rRNA transcription [6]. The identiﬁcation of this candidate
gene in patients with NAIC is unexpected as the requirement for ribo-
some biogenesis is ubiquitous in a developing organism and would
not be just liver-speciﬁc. In situ hybridization showed that mouse
UTP4/Cirhin (mUTP4/Cirhin) is expressed highly in the fetal liver of
day-11.5 mouse embryos [14]. However, it is also highly expressed
in other developing tissues.
Since the elucidation of the R565W mutation in NAIC, efforts have
been made to study the molecular pathogenesis of NAIC using model
organisms. Unfortunately in mice, knockout (−/−) of mUTP4/Cirhin
(also known as TEX292) is embryonic lethal [11] and heterozygotes
(+/−) are phenotypically normal [15]. No knock-in mouse with the
R565W mutation has been documented nor has a liver-speciﬁc
hUTP4/Cirhin knockout been made.
Efforts were also made to use yeast to model NAIC. Yet, introducing
the analogous mutation into yeast Utp4 did not affect growth or ribo-
some biogenesis in yeast [16]. Despite this, yeast proved a valuable
model system to study the molecular genetics of Utp4 and its role in
NAIC. Yeast two-hybrid (Y2H) analysis revealed a map of the protein–
protein interactions (PPIs) among the yeast t-Utp/UtpA subcomplex
members. Its members in yeast include Utp4, Utp5, Utp8, Utp9, Utp10,
Utp15, and Utp17 [4,17,18] (Fig. 1). All are conserved to humans except
Utp8 and Utp9 [6]. Interestingly, the C-terminus of yeast Utp4 (yUtp4),
where the R565W mutation resides, is required for interaction with
Utp8 [16]. These results led to the hypothesis that the R565Wmutation
disrupts the interaction between hUTP4/Cirhin and the then unidenti-
ﬁed human analog of Utp8.
To identify the human analog of Utp8, Freed et al. [19] sought out the
interacting partners of hUTP4/Cirhin. Y2H analysis of a human liver
cDNA library revealed that hUTP4/Cirhin interacts with the metazoan-
speciﬁc, nucleolar protein NOL11. Afﬁnity puriﬁcation followed by
mass spectrometry of a tagged form of hUTP4/Cirhin also identiﬁed
NOL11 aswell as othermembers of the human t-UTP/UTPA subcomplex
including hUTP5, hUTP15, and hUTP17. A subsequent study also foundthat hUTP4/Cirhin is in a complex with hUTP15 [20], supporting the
protein co-puriﬁcation of t-UTP/UTPA subcomplex members by Freed
et al. [19]. Probing its function revealed that NOL11 is required for
pre-rRNA processing and transcription as well as for normal nucleolar
morphology, establishing that NOL11 is the functional human analog
of yeast Utp8. Intriguingly, the R565W mutation in a C-terminal frag-
ment of hUTP4/Cirhin weakened, but did not abolish, its interaction
with NOL11 in the Y2H system [19] (Fig. 2). This suggests a possible
molecular etiology for NAIC: the R565W mutation abrogates the PPI
between hUTP4/Cirhin and NOL11, which may result in defects in pre-
rRNA processing. It is not yet knownwhether this weakened PPI results
in a pre-rRNA processing defect.
In an attempt to understand the pathogenesis of NAIC, another
group also sought out interacting partners of hUTP4/Cirhin [15]. Using
Y2H analysis, hUTP4/Cirhin was found to interact with Cirip, a protein
required for transcription of the HIV-1 LTR enhancer element. However,
hUTP4/Cirhin is nucleolar [19,21], while Cirip is nuclear [15] indicating
that an interaction between these two proteins is not likely required
for the role of hUTP4/Cirhin in ribosome biogenesis.
We are still left to wonder, is nucleolar dysfunction the root cause of
NAIC? If so, how is it that a disease of ribosome biogenesis only affects
the liver? Answers to these questions will have a signiﬁcant impact
both on the understanding of this congenital liver disease and on
human ribosome biogenesis in general.
3. Diseases of UTP14: infertility, scleroderma, and ovarian cancer
A genetic cause of infertility in somemen is due to a mutation in the
human ribosome biogenesis factor, hUTP14c. Utp14 was ﬁrst described
in yeast with the discovery of the SSU processome [3] and is therefore
involved in SSU biogenesis and required for the maturation of the pre-
18S rRNA. hUTP14c is one of three copies of UTP14 in the human
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unusual in that it is a retrogene. Retrogenes originate from fully or
partially spliced mRNAs that are reverse transcribed into DNA and
incorporated into the genome, therefore lacking some or all of the
introns of their original sequence [22]. Many genes on the X chromo-
some have retrogene analogswithin autosomes so that their expression
can occur during X chromosome silencing during meiosis [23].
AlthoughUtp14 is required for the formation and function of the SSU
processome, the speciﬁc function of Utp14 within the SSU processome
has remained elusive. Recently, an A758G mutation in Utp14 rescued
the growth defect found in bud23Δ yeast [24]. Bud23 is required for
A2 cleavage of pre-rRNA and for SSU biogenesis. Wild-type (wt)
Utp14 co-puriﬁed with Bud23 and deletion of BUD23 prevented the
nucleolar localization of Utp14. Utp14 was found in sucrose gradient
fractions containing the SSU processome (early-stage SSU biogenesis),
the U3 snoRNA, and the pre-40S particle containing 20S pre-rRNA
(late-stage SSU biogenesis). Loss of Bud23 prevented association of
Utp14 with the 20S pre-rRNA but not with U3 while the A758G muta-
tion in Utp14 partially restored the association with the 20S pre-rRNA.
These data suggest a role for Utp14 in both early and late stage SSU
biogenesis in concert with Bud23. The exact role of Utp14 in these ribo-
some biogenesis steps remains to be identiﬁed [24].
The mouse Utp14b (mUtp14b) is of particular signiﬁcance in a
mouse model of male infertility. Two groups [25,26] independently
identiﬁed a truncation in mUtp14b due to a premature stop codon as
the causative agent of the infertility phenotype in the juvenile sper-
matogonial depletion (jsd) mouse model ﬁrst described by Beamer
et al. [27]. Male jsd mice undergo a single wave of spermatogenesis
and subsequently fail to differentiate spermatogonia. Interestingly,
they showed that mUtp14b is expressed exclusively in the testes of
mice while the mUtp14a gene on the X chromosome [25] is expressed
ubiquitously [26]. Speciﬁcally, mUtp14b is expressed in the germ cells
[26]. This is in agreement with evidence that infertility could be rescued
in jsdmice by transplanting wild-type spermatogonia [25].Fig. 3. Spermatogonia with apparently normal (A–H) and abnormal (I–L) morphologies in the
Large (I) or numerous (J) nuclear vacuoles are present in nuclei that have diffuse nucleoli and he
large nuclei with increased amounts of heterochromatin (K) and those with highly reticulatedThe mutation identiﬁed in jsd mice replaces a GG dinucleotide in
chromosome 1 in mice with CTTTTC. This introduces a premature stop
codon, truncating the mUtp14b protein product [25,26]. Intriguingly,
the genetic background of amouse affects the jsd phenotype by altering
the average percentage of tubules with differentiating germ cells [28]. A
similar phenomenon has been demonstrated previously in the case of
mouse model of the ribosomopathy, Treacher Collins syndrome [29].
The reason for the effect of genetic background on these phenotypes is
as of yet unknown. To explain why mUtp14b is uniquely expressed in
spermatogonia, it is hypothesized that mUtp14b is required to produce
18S rRNA during meiosis when mUtp14a on the X chromosome is
silenced [26]. As might be expected, abnormal nucleoli and nuclear
vacuoles are found in spermatogonia of jsdmice [30] (Fig. 3) supporting
the hypothesis that a defect in nucleolar function results in aberrant
spermmaturation. Furthermore, mUtp14b is expressed at higher levels
when mUtp14a is silenced during sperm maturation [23].
The human genome contains an analogous gene tomUtp14b. Unlike
mUtp14b, the human UTP14b (hUTP14b) has degenerated into a non-
functional retrogene, or pseudoretrogene [26,31]. However, another
UTP14 retrogene was found in humans in the 3′ UTR of the GT8 gene
(a glycosyl transferase) on chromosome 13, called hUTP14c. hUTP14c
is an intronless copy of the hUTP14a gene that is found on the human
X chromosome [31] and is 66% identical and 77% similar to the amino
acid sequence of mUtp14b. Similar to the situation in the mouse,
hUTP14a is expressed ubiquitously while hUTP14c is expressed in
human testes. It was hypothesized that mutations in hUTP14c cause
infertility in men comparable to the mutation in jsd mice. Screening
234 DNA samples from infertile men revealed that 3 unrelated Cauca-
sian patients had a Y738Xmutation in hUTP14c resulting in a truncated
protein product similar to that found in jsd mice [31]. These patients
were all heterozygous for the mutation indicating a dominant negative
effect of the truncation of hUTP14c. This speciﬁc form of infertility is
indeed a ribosomopathy since a defect in ribosome biogenesis results
in human infertility without any other associated abnormalities.testes of Utp14bjsd mutant mice. Arrowheads indicate nucleoli; arrows indicate vacuoles.
terochromatin typical of differentiated type A spermatogonia. Other abnormalities include
and dispersed nucleoli (L). Bar = 5 μm [30]. Reprinted with permission.
Fig. 4. RT-PCR expression analysis of hUTP14c. Top) Expression of the ancestral X-linked gene, hUTP14a, is ubiquitous, which is consistent with its role in 18S ribosomal RNA processing.
Center) Similarly, GT8 also is expressed in all 18 tissues. Bottom) Expressionpattern of hUTP14c,which is restricted to theovary and testis. AG, adrenal gland; B, brain; BM, bonemarrow; C,
control reaction minus cDNA; H, heart; K, kidney; L, liver; Lu, lung; M, marker; O, ovary; Pl, placenta; Pr, prostate; SC, spinal cord; SG, salivary gland; SM, skeletal muscle; T, testis; Tch,
trachea; Ty, thymus; Tr, thyroid; U, uterus [31]. Reprinted with permission.
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plays a role in ovarian cancer. Besides its expression in testes,
hUTP14c is also expressed in human ovaries (Fig. 4). RT-PCR analysis
of normal human ovarian tissue showed that hUTP14c is expressed in
some but not all individuals. This is consistent with the ﬁnding that
other retrogenes, also thought to be exclusively expressed in the testis,
are found in some but not all normal ovaries [22]. hUTP14a interacts
directly with p53 and knockdown of hUTP14a resulted in increased
levels of p53, while overexpression of hUTP14a led to decreased p53
levels. Furthermore, the interaction between hUTP14a and p53 targets
the latter for degradation [32]. Since hUTP14a and hUTP14c have 90%
identical and 94% similar amino acid sequences, Rohozinski et al. [33]
propose that expression of hUTP14c in the ovary might also result in
decreased levels of p53 similar to overexpression of hUTP14a. Lower
expression of p53 may then lead to susceptibility to tumor generation.
These ﬁndings led to the hypothesis that factors involved in spermato-
genesis in the testis may either pre-dispose or result in the generation
of tumors in the ovary [33]. This fascinating hypothesis has yet to be
tested.
Recently, hUTP14a was also implicated in a human disease.
Scleroderma is a disorder resulting in small blood vessel disease, auto-
immune problems, and ﬁbrosis of connective tissue. In twins affected
with scleroderma, the hUTP14a genewas found to be hypermethylated,
whichdecreases the expression of a gene, compared to unaffected twins
[34]. The role of hypermethylation of hUTP14a in susceptibility to
scleroderma is still unclear.
Unlike the other ribosomopathies, the tissue proclivity of infertility
and ovarian cancer caused by mutations in hUTP14c is easily explained
because of the unusual tissue-speciﬁc expression of this ribosome
biogenesis factor. Perhaps tissue-speciﬁc splicing variants or retrogenes
of other ribosome biogenesis factors are responsible for the tissue
proclivity of other ribosomopathies?
4. Disease of EMG1: Bowen–Conradi syndrome
TheHutterites are a small religious community currently comprising
about 40,000 members primarily living in the Canadian Prairies and
Great Plains of the United States. These 40,000 Hutterites are all
descended from 100 original founders [35]. Consanguineous unions
are common in this isolated population, making rare genetic diseases
more likely. One such apparently genetic and devastating disease affect-
ing Hutterite neonates was ﬁrst described by Bowen and Conradi in
1976 [36]. The original report of the disease described two brothers,
born years apart, whose parents were second cousins. Both had a poor
sucking reﬂex, undescended testes, a prominent nose, micrognathia
(underdeveloped lower jaw), dolichocephaly (increased height of the
skull in relation to the width), “rocker-bottom” feet, generaldevelopmental delays, and failure to thrive. Unusually, their karyotypes
and laboratory ﬁndings were normal. Both brothers died before their
ﬁrst birthdays [36]. Disease presentation was consistent with either
an X-linked or autosomal recessive trait as the parents were unaffected
and both affected individuals were males. However, Hunter et al.
reported 6 additional cases of Bowen–Conradi syndrome (BCS)
(OMIM: 211180) in detail in 1979, three of which were female infants,
and it was therefore concluded that the syndrome had an autosomal
recessive inheritance pattern [37].
Since these early reports, many cases of BCS have been identiﬁed. All
patients present with symptoms similar to the original description of
the syndrome provided by Bowen and Conradi. However, because
the signs and symptoms of BCS are very similar to trisomy 18 and
cerebro-oculo-facial-skeletal syndrome (COFS), it is important to identi-
fy the genetic factors of each for proper diagnosis andmanagement [38].
As patientswith BCS have a normal karyotype, it is distinct from trisomy
18. Furthermore, genome-wide scan and linkage analysis showed that
BCS and its related syndrome, COFS, are distinct syndromes as BCS failed
to map to loci associated with COFS. This analysis also revealed that the
causative gene for BCS was in the chromosome region 12p13.3. [39].
In 2009, Armistead et al. [38] identiﬁed a mutation in the gene,
essential for mitotic growth 1 (EMG1), as the causative agent of BCS
using SNP analysis. EMG1, termed nucleolar essential protein 1
(Nep1) in yeast, is a member of the SSU processome and is thus neces-
sary for small ribosomal subunit assembly and pre-18S rRNA matura-
tion [40]. As expected, the function of EMG1 is necessary for normal
mammalian development, as demonstrated by the pre-implantation
lethality for EMG1 null mice [41]. EMG1 is highly conserved throughout
archaea and eukaryotes. Structural studies in Methanocaldococcus
jannaschii revealed that EMG1 is an N1-speciﬁc pseudouridine methyl-
transferase that catalyzes methylation of the pseudouridine at position
914 of M. jannaschii 16S rRNA. This position is analogous to the
pseudouridine in position 1248 in human 18S rRNA, which is the only
known methylated pseudouridine [42]. A crystal structure of the yeast
Nep1 dimer further supports its role as an N1-speciﬁcmethyltransferase
[43].
Patients with BCS have a D86G mutation in EMG1 that results in
decreased levels of EMG1 protein without affecting mRNA transcript
levels. The aspartate residue at position 86 is themost highly conserved
region of the EMG1 protein and is conserved throughout eukaryotes
and archaea [38] (Fig. 5). In addition, human EMG1 is able to function-
ally replace yeast Nep1 in vivo [44]. To elucidate the molecular details
of the pathogenesis of BCS, studies in yeast with a D90G mutation in
Nep1 (the mutation analogous to D86G in human EMG1) revealed
that the mutant protein retained its methyltransferase activity. EMG1
dimerizes naturally, and a 10-fold increase for the interaction between
monomers of D86G EMG1 as compared to wild-type was observed in
Fig. 5. Protein sequence alignment via ClustalW of the region of the EMG1 protein containing the c.400A/G, p.D86Gmutation. The residues that are completely conserved in all orthologs
are indicated with an asterisk, and the Asp (D) that is mutated in BCS is shown in red [38]. Reprinted with permission.
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gation of themutant EMG1 is responsible for preventing its localization
to the nucleolus. Thus, because enzymatic activity is not affected, the
D86G mutation in EMG1 may cause disease because of a role in ribo-
some assembly and not rRNA modiﬁcation [45].
Indeed, EMG1 plays a critical role in ribosome biogenesis as a ribo-
some assembly factor. Studies in yeast show that EMG1 genetically
interacts with Utp30, another component of the SSU processome. This
interaction supports incorporation of the ribosomal protein Rps19 into
the assembling pre-ribosome [46]. In addition, overexpression of
Rps19 rescues growth defects in EMG1 deﬁcient yeast [47]. This is rath-
er intriguing as human Rps19 is mutated in 25% of patients with the
ribosomopathy, Diamond–Blackfan Anemia (DBA). DBA is a bone mar-
row failure syndrome characterized by decreased or absent red blood
cell progenitors. Patients can also present with various other abnor-
malities including craniofacial defects, various skeletal abnormali-
ties, cancer predisposition, and heart defects [48]. Despite the
associated functions of EMG1 and Rps19, a connection, if one exists,
between their respective ribosomopathies, BCS and DBA, has yet to
be uncovered.
5. Potential diseases modiﬁed by the SSU processome
Two components of the SSU processome have been found to possi-
bly modify human diseases. One of these components is hUTP6/
HCA66, which may modify Neuroﬁbromatosis type 1 (NF1), an autoso-
mal dominant disease marked by the development of neural tumors.
About 5% of NF1 cases are associated with heterozygousmicrodeletions
in genes near the NF1 allele causing additional symptoms of craniofacial
defects, heart malformations, and an increased number of neuroﬁ-
bromas. One such gene that may contain deletions in patients with
NF1 is hUTP6/HCA66 [49]. It has been suggested that the interaction
between hUTP6/HCA66 and the pro-apoptotic factor, Apaf-1, may play
a role in the modiﬁcation of NF1 [50]. However, how deletions in
hUTP6/HCA66 would worsen disease remains to be elucidated. In addi-
tion to NF1, primary open angle glaucoma (POAG) has been proposed to
be modiﬁed by the SSU processome component hUTP21/WDR36 [51].
POAG results in degeneration of the optic nerve and increased intraocu-
lar pressure in patients over 35. Indeed, mutations in hUTP21/WDR36
affect axon growth in the retina in mice [52], and loss of hUTP21/
WDR36 in zebraﬁsh activates the p53 response [53]. Conversely, some
studies claim no association between POAG and hUTP21/WDR36 [54]
while others claim that the effect of mutations in hUTP21/WDR36 is
dependent upon genetic background [55]. More investigation into the
molecular contribution of both of these SSU processome components
is necessary before we can conclude that they are involved in the path-
ogenesis of NF1 or POAG.6. Putative ribosomopathy: Williams–Beuren syndrome
Utp14, whose human analog hUTP14C is mutated in some forms of
male infertility, and the methyltransferase, Bud23, interact with each
other within the yeast SSU processome [24]. Interestingly, Bud23 may
be implicated in the human disease, Williams–Beuren syndrome [56].
This disease is marked by congenital heart defects, craniofacial
dysmorphology (also found in ribosomopathies such as Treacher Collins
syndrome and Diamond–Blackfan Anemia [8]), premature aging, short
stature, hypercalcemia, and cognitive defects. A protein BLAST search
using the amino acid sequence of yeast Bud23 revealed the putative
human methyltransferase, WBSCR22 (NP_059998.2), which is 49%
identical and 67% similar to Bud23 in its amino acid sequence.
WBSCR22 is deleted in patients with Williams–Beuren syndrome [56].
Furthermore, another gene deleted in some patients with Williams–
Beuren syndrome is WBSCR20, which has an amino acid sequence
similar to the nucleolar protein, NOL1. Doll and Grzeschik [56] hypoth-
esized that WBSCR20 may have a role in pre-rRNA processing or ribo-
some assembly. The deletions in WBSCR20 and WBSCR22 result in
hemizygosity and thus haploinsufﬁciency of the gene products similar
to many other ribosomopathies [57]. Due to the homology of
WBSCR22 to Bud23, an SSU processome component, and the predicted
role of WBSCR20 in ribosome biogenesis, we propose that Williams–
Beuren syndrome may be a novel ribosomopathy.
7. Conclusions and perspectives
The complex and vital process of ribosome biogenesis in eukaryotes
is carried out by over 200 factors. Several of these factors associate with
the U3 snoRNA to form a large RNP known as the SSU processome,
which is necessary for the production of fully functional small ribosomal
subunits. As all cells need proteins and therefore ribosomes, it is surpris-
ing that mutations that cause defects in the SSU processome would be
compatible with life. Yet, in the last decade, some genetic diseases
have been attributed to mutations in SSU processome components.
This begs the question, how can only some cell-types be affected by
defects in a process assumed to be necessary for all cells?
Tissue proclivity is of particular interest in NAIC and BCS. The litera-
ture reports only liver disease in patients with NAIC [11]. Despite the
detrimental congenital defects of patients with BCS, few internal
malformations are noted [38]. Whether BCS shows the same extent of
tissue speciﬁcity as other ribosomopathies is less clear. In the case of
hUTP14c, a cell-type speciﬁc form of the UTP14 SSU processome com-
ponent easily explains the tissue proclivity. Are there cell-type speciﬁc
forms of hUTP4/Cirhin and EMG1?
There are other possible mechanisms by which defects in ribosome
biogenesis could affect some tissues and not others. Perhaps defects in
763S.B. Sondalle, S.J. Baserga / Biochimica et Biophysica Acta 1842 (2014) 758–764making the ribosome are sensed differently by different cell-types. All
ribosomes may not be the same [1,58], or all nucleoli may not be the
same in each cell of a multicellular organism. Certain tissues may
sense aberrant translation resulting from dysfunctional ribosomes
differently as well. These hypotheses are not mutually exclusive; they
all may contribute to the pathogenesis of ribosomopathies.
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